Health

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

Positive U.S. Phase 2 safety and efficacy data for opaganib, a leading novel, oral, dual-mechanism drug candidate for moderate-to-severe COVID-19, presented at the World Microbe Forum Opaganib was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated Opaganib’s global 475-patient Phase 2/3 study […]

thaipr.net

22 มิ.ย. 64

INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia’s Ministry of Health for Disease Control

Cambodia’s Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country’s efforts in controlling recent spikes of COVID-19 cases in the region. Rapid antigen tests like INDICAID® have been deployed by the Cambodian Government for widescale screening measures in the capital city Phnom Penh and neighbouring regions, taking […]

thaipr.net

22 มิ.ย. 64

EAN Congress: COVID-19 leads to significant cognitive and behavioural problems in patients

COVID-19 patients suffer from cognitive and behavioural problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology has found [1]. Issues with memory, spatial awareness and information processing problems were identified as possible overhangs from the virus in post-COVID-19 patients who were followed up […]

thaipr.net

21 มิ.ย. 64

World less peaceful as civil unrest and political instability increases due to COVID-19 pandemic, reveals IEP

Today marks the launch of the 15th edition of the Global Peace Index from the international think-tank the Institute for Economics & Peace (IEP). Key results Civil unrest rose globally by 10%, with Belarus recording the largest deterioration. There were 14,871 violent demonstrations, protests and riots recorded globally in 2020. Over 60% of people globally are worried about […]

thaipr.net

17 มิ.ย. 64

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

– 93% efficacy against predominantly circulating Variants of Concern and Variants of Interest– 91% efficacy in high-risk populations– 100% efficacy against variants “not considered Variants of Concern/Interest”– All COVID-19 hospitalizations/death occurred in the placebo group– Company to host investor conference call today at 8:30 am ET Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its…

thaipr.net

15 มิ.ย. 64

PPE Manufacturer Bullard Presents Outstanding Pandemic Response Recognition to Channel Partners

Certificate of Appreciation given for dedication and teamwork in delivering PPE during pandemic Personal protective equipment manufacturer Bullard has presented the Outstanding Pandemic Response Recognition to its valued channel partners in Asia Pacific, Middle East and Africa region for their dedication and efficiency in delivering Bullard’s PPE during the pandemic. In making the presentation, Vincent Lee, […]

thaipr.net

8 มิ.ย. 64
1 … 112 113 114 115 116 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.